Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

The purpose of this study is to determine the sensitivity of Molecular Breast Imaging (MBI) relative to MRI of the breast in patients undergoing MRI for a clinical concern, or abnormal diagnostic mammogram and/or ultrasound study.

Key facts

Study ID

NCT00591864

Run by

Mayo Clinic

People needed

89

Starts

2008-09-01

Expected to finish

2010-12-01

Last updated by the study team

2014-07-09

Who can join

Age: 25 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• This study will include a population of women aged 25 or older who are scheduled for a breast MRI examination at MAYO CLINIC ROCHESTER.
• Patients must not be lactating or pregnant.
• All women of child-bearing potential must have had a negative urine pregnancy test result within 2 days prior to the MBI study.
• women who are scheduled for a breast MRI examination for a clinical concern, problem solving or for further evaluation of invasive breast cancer (e.g. pre-operative staging of known breast cancer).

You may not qualify if…

• They are unable to understand and sign the consent form
• They are pregnant or lactating
• They are physically unable to sit upright and still for 40 minutes.
• The breast MRI is for screening purposes or to determine the status of breast augmentation.
• They have undergone breast surgery within the previous year

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.